Trial intelligence / Profile preview

Heparin versus saline lock to prevent Hickman catheter obstruction

RBR-3ht499Recruiting

Sponsor
Hospital de Clínicas da Universidade Federal do Paraná
Start
Mar 2017
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of heparin and sodium chloride (2 arms), sponsored by Hospital de Clínicas da Universidade Federal do Paraná. Primary endpoints: Catheter occlusion without reflux and Complete catheter occlusion. Started Mar 2017; status: recruiting.

02

Drugs

heparinsodium chloride

Beyond the preview

Go deeper on RBR-3ht499.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-3ht499.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call